Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

SenesTech, Inc. (SNES) Q4 2025 Earnings Call Transcript

SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025.

Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, March 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, will report financial results for its fourth quarter and fiscal year 2025, ended December 31, 2025, after the market close on Thursday, March 12, 2026.

SURPRISE, Ariz., Feb. 18, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) ("SenesTech" or the "Company"), a leader in birth control solutions for managing rodent populations, today reported significant reductions in rodent activity following multi-month deployments of Evolve® Rat Birth Control in two urban locations.

Transition from Third-Party to Internal Management Expected to Increase Revenue and Enhance Margin on E-Commerce Channel Moving Forward While Building on Early Success PHOENIX, Feb. 10, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES) today announced that it will begin directly managing sales of its Evolve™ Rat and Evolve™ Mouse products on Amazon. The change reflects the Company's continued focus on e-commerce as an important distribution channel and will be effective immediately.

Supporting New Zealand's Predator Free 2050 Initiative Initial Stocking Order Fulfilled PHOENIX, Feb. 2, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce that Evolve® has been approved for use in New Zealand by the Ministry for Primary Industries. SenesTech's exclusive distribution partner, Evicom, has been shipped its initial stocking order.

Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor.